7-Hydroxy-CBD-C4 Anticonvulsant Activity in Epilepsy
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current anti-epileptic drugs (AEDs) fail to provide seizure freedom for approximately 30% of epilepsy patients, known as treatment-resistant epilepsy, necessitating the development of new compounds with anticonvulsant properties.
Innovation Solution
The development of novel compounds 7-hydroxy-cannabidol-C4 (7-OH-CBD-C4) and 7-carboxy-cannabidiol-C4 (7-COOH-CBD-C4), which are biologically active and can be administered via various routes, including oral, transdermal, and nasal, for the treatment of epilepsy, either alone or in combination with existing AEDs.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If existing anti-epileptic drugs are used, then most patients can control their symptoms, but 30% of patients cannot achieve seizure freedom
Solution Approach 1:
The patent modifies the chemical structure of existing CBD derivatives by changing parameters such as hydroxylation at position 7 and chain length (C4 variant), creating new compounds with potentially improved anticonvulsant activity to overcome treatment resistance
Solution Approach 2:
The invention combines multiple structural features (cannabidiol backbone, C4 chain, 7-hydroxy or 7-carboxy substitution) to create composite molecular structures that may synergistically enhance anticonvulsant properties while reducing treatment resistance
2Reliability
If new compounds are developed for treatment-resistant epilepsy, then potential therapeutic benefits increase, but development complexity and time increase
Solution Approach 1:
The patent focuses on specific structural modifications (7-hydroxy and 7-carboxy groups on C4-cannabidiol) rather than exploring all possible CBD derivatives, segmenting the search space to identify promising candidates more efficiently
Solution Approach 2:
The patent builds upon preliminary data showing anticonvulsant activity of related CBD derivatives, using this prior knowledge to guide the development of more potent compounds and reduce unnecessary exploration
Data Source
AI summary
The present invention relates to compounds that are pharmaceutically active and methods of preparation thereof. The compounds of the invention are 7-hydroxy-cannabidol-C4 (7-OH-CBD-C4) and 7-carboxy-cannabidiol-C4 (7-COOH-CBD-C4). The compounds of the invention are related to cannabidiol (CBD). CBD is a non-psychoactive cannabinoid which has been used to treat various diseases and disorders. While such treatments hold promise, there remains a need in the art for more effective treatments and this has been brought about by way of the compounds of the invention.